Alignment Healthcare - ALHC Stock Forecast, Price & News

12 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Alignment Healthcare in the last twelve months. There are currently 1 hold rating and 11 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" ALHC shares.
View ALHC analyst ratings or view top-rated stocks.

12 Wall Street research analysts have issued twelve-month price objectives for Alignment Healthcare's shares. Their ALHC share price forecasts range from $14.00 to $21.00. On average, they predict the company's share price to reach $18.64 in the next year. This suggests a possible upside of 18.0% from the stock's current price.
View analysts price targets for ALHC or view top-rated stocks among Wall Street analysts.

Alignment Healthcare's stock was trading at $14.06 at the start of the year. Since then, ALHC shares have increased by 12.4% and is now trading at $15.80.
View the best growth stocks for 2022 here.

The company is scheduled to release its next quarterly earnings announcement on Thursday, November 3rd 2022.
View our ALHC earnings forecast.

Alignment Healthcare, Inc. (NASDAQ:ALHC) issued its earnings results on Thursday, August, 4th. The company reported ($0.06) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.26) by $0.20. Alignment Healthcare had a negative trailing twelve-month return on equity of 47.96% and a negative net margin of 11.20%. During the same quarter in the previous year, the company earned ($0.25) EPS.

Alignment Healthcare updated its third quarter 2022 earnings guidance on Thursday, August, 25th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $330.00 million-$335.00 million, compared to the consensus revenue estimate of $331.14 million.

(ALHC) raised $490 million in an IPO on Friday, March 26th 2021. The company issued 27,200,000 shares at $17.00-$19.00 per share. Goldman Sachs, Morgan Stanley, J.P. Morgan, BofA Securities and William Blair served as the underwriters for the IPO and UBS Investment Bank, Piper Sandler and Raymond James were co-managers.

Alignment Healthcare trades on the NASDAQ under the ticker symbol "ALHC."

Alignment Healthcare's stock is owned by many different institutional and retail investors. Top institutional shareholders include FMR LLC (8.99%), Price T Rowe Associates Inc. MD (4.70%), Brown Advisory Inc. (1.91%), State Street Corp (0.73%), Amundi (0.69%) and Goldman Sachs Group Inc. (0.60%). Insiders that own company stock include Atlantic (Aln Hlth) L General, Dawn Christine Maroney, Dinesh M Kumar, Donald Steven Furman, Jeffrey H Margolis, John E Kao, Michael Curtis Foster, Richard A Cross, Robert Thomas Freeman, Warburg Pincus Llc and Warburg Pincus Partners Gp Llc.
View institutional ownership trends.

Shares of ALHC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of ALHC stock can currently be purchased for approximately $15.80.

Alignment Healthcare (NASDAQ:ALHC) has a market capitalization of $2.96 billion and generates $1.17 billion in revenue each year. The company earns $-195,290,000.00 in net income (profit) each year or ($0.82) on an earnings per share basis.

The company employs 847 workers across the globe.

Alignment Healthcare's mailing address is 1100 W. TOWN AND COUNTRY ROAD SUITE 1600, ORANGE CA, 92868. The official website for the company is www.alignmenthealthcare.com. The company can be reached via phone at 844-310-2247 or via email at alignmentir@westwicke.com.